Current condition and prognosis of tumor immunotherapy: a second opinion.
D000917:Antibody Formation; D000951:Antigens, Neoplasm / Q000032:analysis; D000954:Antigens, Surface / Q000032:analysis; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D011379:Prognosis
D000951:Antigens, Neoplasm; D000954:Antigens, Surface